1Y Close · As of Aug 26, 2026
D&D Pharmatech operates in the Professional Services sector.
Legal name: D&D Pharmatech Inc.
In fiscal year 2025, D&D Pharmatech (347850) reported revenue of 4.3 billion KRW, down 62.4% from 11.4 billion KRW a year earlier.
Operating profit was -34.0 billion KRW and net income was -24.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 2.58 trillion KRW, with a P/B of 32.68.
These figures can be verified in the DART filing (receipt no. 20260320001088).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 4.3B | -34.0B | -24.0B |
| 2024 | 11.4B | -25.0B | -29.5B |
| 2023 | 18.7B | -13.5B | 3.4B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-21 | 투자판단관련주요경영사항(임상시험결과) (대사이상지방간염 (MASH)) |
| 2026-08-14 | Semi-Annual Report (2026.06) |